MytoGroup Program

MS May Be Diagnosed Through Eye Scan

Research involving optical coherence tomography (OCT) may have uncovered a means of evaluating brain damage resulting from multiple sclerosis. Eye scans are commonly employed in ophthalmology.

No radiation results from a scan. The cost of an eye scan is only 10 percent of what it would cost to perform an MRI.
Read more
Clinical Trial To Test If Vitamin D Can Prevent Multiple Sclerosis

A new clinical trial set to take place in Australia and New Zealand will test whether vitamin D can prevent multiple sclerosis (MS) in those at risk of developing the disease.

The trial will focus on the possibility of using vitamin D supplementation to prevent a diagnosis of MS following a person’s presentation with the first symptoms that may lead to a diagnosis of MS. It will also test appropriate dosage levels and safety; information that may eventually lead to an effective prevention strategy for MS.
Read more
Dual Multiple Sclerosis Finding May Change Therapy

A cellular signature seen in the blood of multiple sclerosis patients may help determine their likelihood of relapse, potentially influencing which therapy physicians prescribe, a study found.

Differences in patients’ blood cells delineated them into two groups, one with a 40 percent lower risk of relapse, according to research today in the journal Science Translational Medicine. The findings eventually could help doctors determine whether to prescribe a drug such as Biogen Idec Inc. (BIIB)’s Avonex, which is moderately effective with fewer side effects, or its Tysabri, an aggressive therapy with greater safety issues, said Philip De Jager, a neurologist at Harvard Medical School in Boston and a study author.
Read more
Controversial MS treatment receives ethical approval, clinical tests to begin in B.C.

A long-awaited national trial of a controversial experimental treatment for multiple sclerosis has been given the go-ahead and will soon begin recruiting patients in B.C. and Quebec.

The $6-million trial of “liberation therapy,” a type of balloon angioplasty that widens the jugular and azygous veins, has received ethical approval to proceed, federal Health Minister Leona Aglukkaq announced Friday.

About 100 people in B.C. and Quebec are expected to take part in the trial, which is a collaboration between the federal government, British Columbia, Quebec and the MS Society of Canada.
Read more

Myto Group

MytoGroup is looking for 5 more participants for it’s 12 week program (download program details)

If you think you make a great candidate please apply by filling out form on Apply Now or clicking here.

MS May Be Diagnosed Through Eye Scan

Clinical Trial To Test If Vitamin D Can Prevent Multiple Sclerosis

Dual Multiple Sclerosis Finding May Change Therapy

Controversial MS treatment receives ethical approval, clinical tests to begin in B.C.